U.S. Machinery Stock News

NYSEAM:GORO
NYSEAM:GOROMetals and Mining

Gold Resource (GORO): Losses Worsen at 66.7% Annually, Undercutting Turnaround Narratives

Gold Resource (GORO) remains unprofitable, with net losses worsening at a rate of 66.7% per year over the past five years, and profit margins still in negative territory. Revenue is forecast to grow 8.2% annually, which is slower than the US market average of 10.5%. For investors, the company’s faster-increasing losses and underwhelming revenue outlook put pressure on sentiment this earnings season. See our full analysis for Gold Resource. Next, we will see how these headline results stack up...
NYSE:WOW
NYSE:WOWMedia

WOW (WideOpenWest): Losses Worsen, Profitability Outlook Challenges Bull Case

WideOpenWest (WOW) remains in the red, showing no recent progress in improving its profit margins. Over the last five years, losses have worsened at an annual rate of 12.7%. Consensus expects revenue to decline 2.8% per year over the next three years. With forecasts pointing to continued unprofitability, investors face a story of persistent losses and declining top-line numbers in the coming years. See our full analysis for WideOpenWest. Next, we will compare these headline numbers with the...
NYSE:RDN
NYSE:RDNDiversified Financial

Radian Group (RDN) Value Discount Persists as Margin Compression Challenges Bullish Narratives

Radian Group (RDN) posted annual earnings growth of 5.1% over the past five years, but its earnings slipped over the last year and are projected to rise only 3.7% annually going forward. Revenue is on track to grow at 6.5% each year, trailing the US market average of 10.5%. The recent net profit margin came in at 45.6%, down from 47.1% last year. Investors may see the lower price-to-earnings ratio of 7.9x as a value opportunity versus its peers. However, growth prospects appear more modest...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Match Group (MTCH): Profit Margins Slip, Undermining Bullish Narratives Despite Strong Valuation

Match Group (MTCH) has seen earnings rise 7% per year over the last five years, and profits are forecast to grow at 11.7% per year going forward. Net profit margins in the latest period landed at 15.6%, down from 18.7% a year earlier. Revenue growth is expected to trail the broader market, with forecasts for a 5.4% annual pace compared to the US market’s 10.5%. See our full analysis for Match Group. Next up, we will see how these headline numbers play out against the current narratives and...
NYSE:U
NYSE:USoftware

Unity (U) Losses Accelerate 10.8% Annually, Extending Profit Worries Versus Growth Narratives

Unity Software (U) remains in the red, with losses deepening by 10.8% per year over the past five years and no notable shift in profitability metrics. Revenue is forecast to grow at 10% annually, slightly lagging the broader US market's 10.5%. With shares trading at $42.36, well above the estimated fair value of $36.45 and a price-to-sales ratio of 10.1x that surpasses both peer and industry averages, investors see a company priced for growth but still searching for sustained profits in the...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Stoke Therapeutics (STOK) Profitability Milestone Tests Bullish Narratives as Earnings Face Declines

Stoke Therapeutics (STOK) has moved into profitability over the past year and is now forecasting revenue growth of 20.1% per year, which handily outpaces the broader US market's 10.5% annual growth expectation. However, earnings are projected to decline by 5.6% each year over the next three years, suggesting the company's recently achieved profit status may be tested as the bottom line comes under pressure. The premium valuation and mixed outlook put investor attention squarely on how...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Astera Labs (ALAB) Turns Profitable, Challenges Valuation Narratives With 27.1% Earnings Growth Forecast

Astera Labs (ALAB) has just turned profitable, with forecasts calling for earnings to grow at 27.1% per year and revenue to rise 23.5% annually, both comfortably ahead of US market averages. The company’s net profit margin has flipped from negative to positive, and its high quality earnings profile comes as shares are trading at a remarkable premium: a Price-To-Sales ratio of 49.9x, well above both direct semiconductor peers and the industry average. With no major risks or insider selling...
NYSE:MOS
NYSE:MOSChemicals

Mosaic (MOS): One-Off Gain Drives 284% Earnings Growth, Raising Profit Quality Concerns

Mosaic (MOS) delivered remarkable earnings growth of 284% over the last year, a sharp turnaround from its five-year average decline of -8.4% per year. Net profit margins strengthened significantly, moving from 2% to 8.4%. However, this surge was driven in part by a one-off $652.2 million gain, making some of these earnings non-recurring. Looking ahead, sentiment will weigh Mosaic’s low Price-to-Earnings Ratio of 8.9x and pricing below analyst fair value estimates against the forecast for...
NasdaqGS:VRTX
NasdaqGS:VRTXBiotechs

Vertex Pharmaceuticals (VRTX): Profit Margins Improve, But Revenue Growth Lags Market Into Earnings Season

Vertex Pharmaceuticals (VRTX) is forecasting revenue growth of 8.8% annually, trailing the broader US market’s 10.5% pace. Earnings are expected to rise 13.3% per year, slower than the US average of 16%. Over the past five years, the company’s earnings have actually declined by 10.4% per year, yet Vertex recently moved into profitability and has improved its net profit margins. This puts a spotlight on ongoing improvements in earnings quality this season. See our full analysis for Vertex...
NYSE:JXN
NYSE:JXNDiversified Financial

Jackson Financial (JXN): Profitability Turnaround Forecast Reinforces Bullish Valuation Narrative

Jackson Financial (JXN) posted a net loss, with losses having deepened at a rate of 14.3% per year over the past five years. Looking ahead, analysts project revenue growth of 2.4% per year and earnings growth of 5.68% annually, with JXN expected to reach profitability within the next three years. For investors, these figures signal that the current unprofitability may be a temporary challenge. A turnaround could be on the horizon as earnings are forecast to improve. See our full analysis for...
NYSE:BXP
NYSE:BXPOffice REITs

Is BXP Attractively Priced After Recent Share Decline and Volatile Market Moves?

Ever wondered if BXP is attractively priced right now? Whether you are bargain hunting or just want to avoid overpaying, it is a question worth asking. BXP shares recently closed at $69.73 and have seen some volatility, dropping 5.9% in the last week and 7.8% over the past month, with a year-to-date move of -5.4% and a one-year decline of 9.8%. Despite this, there has been a 16.4% gain over three years. Much of this movement has followed headlines about the shifting outlook for commercial...
NYSE:ACA
NYSE:ACAConstruction

Assessing Arcosa’s Value After 7% Stock Jump Driven by Infrastructure Bill News

Wondering if Arcosa's current share price is a steal or too good to be true? You are not alone in wanting to get to the bottom of its real value. In just the last week, Arcosa's stock climbed 7.1%, adding to an 8.6% gain over the past month and bringing its five-year return to an impressive 86.6%. Much of this momentum follows recent headlines about new infrastructure spending bills and Arcosa's strategic position to benefit from heightened demand in the construction industry. Investors are...
NYSE:SPG
NYSE:SPGRetail REITs

Simon Property Group (SPG): Net Margin Declines to 36.4%, Challenging Bullish Valuation Narratives

Simon Property Group (SPG) reported a net profit margin of 36.4%, a notable decrease from last year's 41.4%. Earnings have grown at an annual rate of 9.7% over the past five years. Despite high earnings quality, growth is projected to slow as revenue is forecast to rise by just 1.8% per year and EPS by 3.39% per year, both trailing the US market averages. Investors are weighing a muted growth outlook and margin compression against the fact that shares trade below one estimate of fair value...
NasdaqGS:CCSI
NasdaqGS:CCSISoftware

Consensus Cloud Solutions (CCSI): Exploring Valuation Ahead of Q3 2025 Earnings and Upgraded Analyst Forecasts

Consensus Cloud Solutions (CCSI) is drawing increased attention ahead of its upcoming Q3 2025 earnings release, as recent updates to revenue and earnings estimates have sparked renewed interest among investors. See our latest analysis for Consensus Cloud Solutions. Consensus Cloud Solutions’ share price has surged 42.6% in the past 90 days, while its 1-year total shareholder return stands at 22.3%. The momentum suggests building optimism ahead of earnings, even as the stock continues to...
NasdaqGS:GOGO
NasdaqGS:GOGOWireless Telecom

Could Gogo’s (GOGO) 5G Test Progress Hint at a New Era of Competitive Advantage?

Gogo has begun in-flight testing of its next-generation 5G air-to-ground connectivity network for North American customers, marking a significant step toward commercial rollout before the end of 2025 and following validation of key hardware and software. An interesting detail is that 400 aircraft have already been pre-provisioned for the new 5G service, up from 300 in the last three months, highlighting growing client anticipation ahead of full activation and expected service-driven revenue...
NYSE:KW
NYSE:KWReal Estate

Kennedy-Wilson Stock Drops 25% in 2024 Amid Real Estate Volatility, Is Opportunity Emerging?

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Is Viridian Therapeutics a Bargain After Pipeline Results Spark Optimism?

Wondering if Viridian Therapeutics is truly a bargain or simply treading water? Here is a closer look at what makes this stock potentially interesting for value-minded investors. The share price climbed 8.3% in the past month but is still down 7.1% over the last year. This may suggest shifting investor sentiment and possible untapped growth. Markets have responded dynamically to the company’s recent announcement of promising results from its pipeline treatments for rare diseases. These...